GHSI — Guardion Health Sciences Share News
0.000.00%
Last trade - 00:00- $4.22m
- -$10.60m
- $12.25m
Brief: Guardion Health Sciences Announces Completion Of Sale Of Its Viactiv® Brand And Business To Doctor’S Best Inc. And Stockholder Approval Of Plan Of Liquidation And Dissolution
Brief: Guardion Health Sciences Announces Its Largest Stockholder Has Voted In Favor Of Proposals To Sell The Viactiv Business
Guardion Health Sciences Inc reports results for the quarter ended in March - Earnings Summary
Guardion Health Sciences Inc expected to post a loss of 88 cents a share - Earnings Preview
Brief: Xiamen Kingdomway's U.S. Unit To Buy Activ Nutritional
U.S. STOCKS ON THE MOVE-Biogen, Otis, Cigna
U.S. STOCKS ON THE MOVE-Boeing, Mondelez International, Novavax
U.S. STOCKS ON THE MOVE-Starbucks, Walmart, Guardion Health
Guardion Health up on deal to sell subsidiary unit for $17.2 mln
Brief: Guardion Health Sciences Announces Agreement To Sell Well-Known Viactiv® Brand And Business To Doctor’s Best Inc.
Brief: Guardion Health Sciences, Inc. Q2 Gross Margin 44.8%
Guardion Health Sciences Inc expected to post a loss of 93 cents a share - Earnings Preview
Brief: Guardion Health Sciences Approves Reduction In Size Of Board To Four Directors
Brief: Guardion Health Sciences Announces Appointment Of Former Neutrogena And Coca-Cola Executive Jan Hall As President And Chief Executive Officer
Brief: Guardion Health Sciences Announces Financial Results For The Quarter Ended March 31, 2023
Guardion Health Sciences Inc expected to post a loss of $1.13 a share - Earnings Preview
Brief: Guardion Health Sciences Announces Financial Results For The Year Ended December 31, 2022
Brief: Guardion Health Sciences Hires Alantra LLC As Its Financial Advisor To Explore Strategic Alternatives To Maximize Stockholder Value
Brief: Guardion Health Sciences Inc Regains Compliance With Nasdaq Continued Listing Requirements